Tilray Inc (NASDAQ:TLRY – Get Free Report)’s share price traded up 1.4% during trading on Friday . The company traded as high as $1.77 and last traded at $1.77. 3,958,579 shares were traded during trading, a decline of 84% from the average session volume of 25,007,477 shares. The stock had previously closed at $1.74.
Tilray Trading Up 1.1 %
The company has a quick ratio of 1.42, a current ratio of 2.27 and a debt-to-equity ratio of 0.10. The stock has a market cap of $1.48 billion, a PE ratio of -4.01 and a beta of 2.13. The stock has a 50-day moving average of $1.80 and a 200 day moving average of $1.87.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its earnings results on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The firm had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. During the same period last year, the firm earned ($0.15) earnings per share. Tilray’s revenue for the quarter was up 24.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Tilray Inc will post -0.16 earnings per share for the current year.
Institutional Trading of Tilray
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Recommended Stories
- Five stocks we like better than Tilray
- How to buy stock: A step-by-step guide for beginnersÂ
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- Energy and Oil Stocks Explained
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- How Investors Can Find the Best Cheap Dividend Stocks
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.